Reverse Triangular Mergers Do Not Trigger Anti-Assignment Clauses

by Stinson Leonard Street - Dodd-Frank and the Jobs Act

The Delaware chancery court recently restored some clarity to its jurisprudence regarding the effect of a reverse triangular merger (RTM) on contracts of the target company that contain anti-assignment clauses.  An April 2011 ruling on a motion to dismiss had hinted that, in some circumstances, an RTM could be construed as an assignment by operation of law even though the assets of the surviving corporation remain titled with the surviving corporation.  In a summary judgment decision, the chancery court has now clarified that an RTM does not result in an assignment by operation of law with respect to the surviving corporation.

In an RTM, the buyer forms a subsidiary company that is then merged with and into the target company, with the target company surviving.  The merger subsidiary formed by the buyer ceases to exist as a result of the merger.  Meanwhile, the target company assumes all of the assets and liabilities formerly of the merger subsidiary.   

In the transaction at issue, Roche Diagnostics (Roche) sought to acquire BioVeris Corporation (BioVeris) in a reverse triangular merger. BioVeris held some key intellectual property rights pursuant to an agreement with Meso Scale Diagnostics (Meso Scale).  The Meso Scale agreement contained an anti-assignment provision that prohibited BioVeris from assigning the agreement “by operation of law or otherwise” without the prior written consent of Meso Scale.

To complete the acquisition, Roche created a new subsidiary (merger sub), and then merged the merger sub with and into BioVeris.  The BioVeris stockholders were paid out in cash, leaving Roche the sole stockholder of BioVeris after the transaction.  In the merger between merger sub and BioVeris, BioVeris was the surviving corporation.  According to Meso Scale, “within months of the BioVeris Merger, Roche laid off all of its approximately 200 employees, vacated the BioVeris facility in Maryland, and notified existing customers that BioVeris’s product lines were being discontinued, leaving BioVeris as nothing more than a holding company for its intellectual property and license rights.”  Even though the intellectual property rights remained titled in BioVeris after the RTM, Meso Scale brought suit claiming that, under the circumstances (i.e., a situation in which the target company is retained only as a shell holding company after the transaction), the RTM constituted an assignment by operation of law without Meso Scale’s prior written consent, in violation of the agreement.

Roche moved to dismiss the lawsuit by Meso Scale under Rule 12(b)(6) for failure to state a claim.  In December of 2010, the Delaware chancery court heard arguments on Roche’s motion to dismiss.  In its ruling dated April 8, 2011, the chancery court refused to dismiss the complaint, finding that Meso Scale’s argument was a reasonable interpretation that could not be dismissed at the 12(b)(6) stage. 

Even though the chancery court’s decision in refusing to dismiss the Meso Scale complaint in April of 2011 was not a decision on the merits, commentators took it as a hint that the chancery court may be willing to find that an anti-assignment clause applicable to the target could be triggered by an RTM, especially in a situation in which the buyer treats the target company as a mere shell and operates as if it (the buyer) had directly acquired the rights of the target company.  A finding like that would be contrary to the traditional understanding that an RTM does not trigger anti-assignment provisions in contracts of the surviving corporation because the contractual rights of the target in the RTM are never transferred.

On February 22, 2013, the chancery court issued its decision on Roche’s motion for summary judgment, which had made the same arguments present in its prior motion to dismiss.  This time, though, the chancery court agreed with Roche that the anti-assignment clause was not triggered.  The court pointed to Section 259(a) of the Delaware General Corporation Law, which provides that the effect of an RTM is the transfer of the assets and liabilities of the non-surviving corporation to the surviving corporation, and therefore does not result in a transfer of the assets and liabilities of the surviving corporation.  The court also noted that, since the great weight of commentary and case law relating to RTMs states that they do not trigger anti-assignment clauses with respect to contracts of the surviving corporation, it was unlikely that the parties intended a different result to apply when they entered into the agreement in question. 

As for Meso Scale’s argument that this RTM had the same effect as an assignment of the intellectual property rights of BioVeris directly to Roche regardless of the technical form of the transaction, the court pointed to the doctrine of independent legal significance under Delaware law, which provides that “The mere fact that the result of actions taken under one section [of the DGCL] may be the same as the result of action taken under another section does not require that the legality of the result must be tested by the requirements of the section.” (pp. 39-40 of the opinion).

Check frequently for updated information on the JOBS Act, the Dodd-Frank Act and other important securities law matters.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Stinson Leonard Street - Dodd-Frank and the Jobs Act | Attorney Advertising

Written by:

Stinson Leonard Street - Dodd-Frank and the Jobs Act

Stinson Leonard Street - Dodd-Frank and the Jobs Act on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.